JP2010521514A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521514A5
JP2010521514A5 JP2009553997A JP2009553997A JP2010521514A5 JP 2010521514 A5 JP2010521514 A5 JP 2010521514A5 JP 2009553997 A JP2009553997 A JP 2009553997A JP 2009553997 A JP2009553997 A JP 2009553997A JP 2010521514 A5 JP2010521514 A5 JP 2010521514A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
cyclopentyl
composition
acceptable excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009553997A
Other languages
English (en)
Other versions
JP5087640B2 (ja
JP2010521514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/052847 external-priority patent/WO2008113711A1/en
Publication of JP2010521514A publication Critical patent/JP2010521514A/ja
Publication of JP2010521514A5 publication Critical patent/JP2010521514A5/ja
Application granted granted Critical
Publication of JP5087640B2 publication Critical patent/JP5087640B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (7)

  1. 式(I)
    Figure 2010521514
    (式中、R2は、シクロペンチル及びシクロヘキシルからなる群から選択される
    の化合物及び医薬的に許容可能なその塩。
  2. R2がシクロペンチルである請求項の化合物。
  3. 4−(9−シクロペンチル−7,7−ジフルオロ−5−メチル−6−オキソ−6,7,8,9−テトラヒドロ−5H−ピリミド[4,5−b][1,4]ジアゼピン−2−イルアミノ)−3−メトキシ安息香酸、及び医薬的に許容可能なその塩。

  4. Figure 2010521514
    を有する化合物。
  5. 請求項1の化合物及び医薬的に許容可能な賦形剤を含んでなる組成物。
  6. 請求項の化合物及び医薬的に許容可能な賦形剤を含んでなる組成物。
  7. 請求項3の化合物及び医薬的に許容可能な賦形剤を含んでなる組成物。
JP2009553997A 2007-03-22 2008-03-11 Plk1阻害剤として有用な置換ピリミドジアゼピン Expired - Fee Related JP5087640B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91935807P 2007-03-22 2007-03-22
US60/919,358 2007-03-22
PCT/EP2008/052847 WO2008113711A1 (en) 2007-03-22 2008-03-11 Substituted pyrimidodiazepines useful as plk1 inhibitors

Publications (3)

Publication Number Publication Date
JP2010521514A JP2010521514A (ja) 2010-06-24
JP2010521514A5 true JP2010521514A5 (ja) 2011-04-21
JP5087640B2 JP5087640B2 (ja) 2012-12-05

Family

ID=39415299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009553997A Expired - Fee Related JP5087640B2 (ja) 2007-03-22 2008-03-11 Plk1阻害剤として有用な置換ピリミドジアゼピン

Country Status (24)

Country Link
US (1) US7517873B2 (ja)
EP (1) EP2139892B1 (ja)
JP (1) JP5087640B2 (ja)
KR (1) KR101157848B1 (ja)
CN (2) CN102746175B (ja)
AR (1) AR065794A1 (ja)
AT (1) ATE524472T1 (ja)
AU (1) AU2008228303B2 (ja)
BR (1) BRPI0809088A2 (ja)
CA (1) CA2680757A1 (ja)
CL (1) CL2008000785A1 (ja)
CY (1) CY1112102T1 (ja)
DK (1) DK2139892T3 (ja)
ES (1) ES2371832T3 (ja)
HK (1) HK1139936A1 (ja)
HR (1) HRP20110807T1 (ja)
IL (1) IL200617A (ja)
MX (1) MX2009010034A (ja)
PE (1) PE20120495A1 (ja)
PL (1) PL2139892T3 (ja)
PT (1) PT2139892E (ja)
SI (1) SI2139892T1 (ja)
TW (1) TWI363629B (ja)
WO (1) WO2008113711A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5380447B2 (ja) * 2007-08-15 2014-01-08 バーテックス ファーマシューティカルズ インコーポレイテッド 増殖性疾患の処置のための、ヒトタンパク質キナーゼplk1ないしplk4の阻害剤としての4−(9−(3,3−ジフルオロシクロペンチル)−5,7,7−トリメチル−6−オキソ−6,7,8,9−テトラヒドロ−5h−ピリミド[4,5−b[1,4]ジアゼパン−2−イルアミノ]−3−メトキシベンザミド誘導体
WO2009042711A1 (en) * 2007-09-25 2009-04-02 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
CA2700979C (en) 2007-09-28 2017-06-20 Cyclacel Limited Pyrimidine derivatives as protein kinase inhibitors
WO2009067547A1 (en) * 2007-11-19 2009-05-28 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
WO2009153197A1 (en) * 2008-06-18 2009-12-23 F. Hoffmann-La Roche Ag Halo-substituted pyrimidodiazepines as plkl inhibitors
EA021377B9 (ru) 2008-12-09 2015-09-30 Джилид Сайэнс, Инк. Модуляторы толл-подобных рецепторов
EP3255047B1 (en) * 2009-01-06 2021-06-30 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone kinase scaffold compounds and uses in treating disorders
ES2604667T3 (es) 2009-06-17 2017-03-08 Vertex Pharmaceuticals Incorporated Inhibidores de la replicación de virus de influenza
ES2661850T3 (es) 2009-09-14 2018-04-04 Gilead Sciences, Inc. Moduladores de receptores del tipo toll
CA2822057A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
JP6553589B2 (ja) 2013-03-15 2019-07-31 ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド ピリミド−ジアゼピノン化合物および障害の治療方法
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
TWI652014B (zh) * 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
MX2016006200A (es) 2013-11-13 2016-08-08 Vertex Pharma Metodos para preparar inhibidores de la replicacion de virus de influenza.
EP3068776B1 (en) 2013-11-13 2019-05-29 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP2017504651A (ja) * 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジアゼパン誘導体の使用
RU2016134947A (ru) 2014-01-31 2018-03-01 Дана-Фарбер Кансер Институт, Инк. Производные диаминопиримидин бензолсульфона и их применение
TWI806081B (zh) 2014-07-11 2023-06-21 美商基利科學股份有限公司 用於治療HIV之toll樣受體調節劑
JP2017526741A (ja) 2014-08-08 2017-09-14 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジアゼパン誘導体およびその使用
UY36298A (es) 2014-09-16 2016-04-29 Gilead Science Inc Formas sólidas de un modulador del receptor tipo toll
PT3194402T (pt) 2014-09-16 2019-02-11 Gilead Sciences Inc Métodos de preparação de moduladores dos recetores tipo toll
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2750164C2 (ru) 2015-09-11 2021-06-22 Дана-Фарбер Кэнсер Инститьют, Инк. Цианотиенотриазолодиазепины и пути их применения
BR112018004617A2 (pt) 2015-09-11 2018-09-25 Dana Farber Cancer Inst Inc acetamida tienotriazoldiazepinas e usos das mesmas
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
WO2017177092A1 (en) * 2016-04-07 2017-10-12 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone kinase scaffold compounds and methods of treating pi3k-mediated disorders
WO2021061894A1 (en) * 2019-09-27 2021-04-01 Dana-Farber Cancer Institute, Inc. Erk5 degraders as therapeutics in cancer and inflammatory diseases
KR20210122163A (ko) * 2020-03-27 2021-10-08 (주) 업테라 Plk1의 선택적 분해를 유도하는 피라졸로퀴나졸린 유도체 화합물
WO2022145989A1 (ko) * 2020-12-31 2022-07-07 (주) 업테라 선택적 plk1 억제제로서의 피리미도디아제핀 유도체
MX2024001774A (es) 2021-08-10 2024-04-24 Uppthera Inc Compuesto inductor de la degradacion de plk1 novedoso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2002934A3 (cs) * 1999-09-17 2002-07-17 Abbott Gmbh & Co. Kg Inhibitory kinázy jako terapeutická činidla
CN1551881A (zh) * 2001-09-04 2004-12-01 ���ָ��Ӣ��ķ�������Ϲ�˾ 新颖二氢喋啶酮,其制备方法及作为药物组合物的用途
DE602007008837D1 (de) * 2006-02-14 2010-10-14 Vertex Pharma Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
TW200808325A (en) 2006-07-06 2008-02-16 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2010521514A5 (ja)
JP2014515013A5 (ja)
JP2010523692A5 (ja)
JP2015512931A5 (ja)
JP2006526031A5 (ja)
JP2010536766A5 (ja)
JP2008546809A5 (ja)
JP2008520662A5 (ja)
JP2011518833A5 (ja)
JP2011513196A5 (ja)
JP2009502743A5 (ja)
JP2012502037A5 (ja)
JP2010504343A5 (ja)
JP2009535462A5 (ja)
JP2008518890A5 (ja)
JP2011527667A5 (ja)
JP2008513510A5 (ja)
JP2009501198A5 (ja)
JP2014500861A5 (ja)
JP2007532575A5 (ja)
JP2008517020A5 (ja)
JP2010507589A5 (ja) Cb1受容体モジュレーターとしての1,5−ジフェニル−3−ピリジニルアミノ−1,5−ジヒドロピロリジン−2−オン
JP2009501704A5 (ja)
JP2010521516A5 (ja)
JP2010508310A5 (ja)